Registry series: Germ Cell Cancer (2008)

The Council of Europe does not deal with germ cell cancer as a category but has more generalized guidelines for testicular and ovarian cancers, as well as CNS germ cell tumors. - Most recent risk assessment for testicular cancer (Council of Europe, 2025): Testicular cancer diagnosed during procurement: Testicular cancer diagnosed at retrieval is considered an absolute contraindication to donation. Testicular cancer in donor history: Given the good treatment response of testicular cancer in general and stage 1 cancers in particular, a stage 1 cancer with at least 5 years recurrence-free follow-up is likely to be associated with minimal risk. For other stages a higher transmission risk should be assumed, but risk will decrease with recurrence-free time and increasing probability of cure. - Most recent risk assessment for ovarian cancer (Council of Europe, 2025): Ovarian cancer diagnosed during donor procurement: Ovarian cancer is considered an unacceptable risk for organ donation. Ovarian cancer in the donor history: Treated ovarian cancer is considered high-risk for organ donation. Depending on initial stage, grade, therapy and duration of recurrence-free survival (> 5 years), the risk category might decrease for some individuals.